This is a full-fledged reverse merger in which Epirus is acquiring ZLCS’ Nasdaq listing as an alternative to an IPO. After the merger, existing ZLCS shareholders will own 14-19% of the new company, depending on ZLCS’ cash balance at the time of the closing. (ZLCS’ non-financial assets other than its Nasdaq listing are essentially being valued at nil.)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.